CFDE Data Portal | Search MIR3682

	Label	Description
	MIR3682 associations Collection (Entity type)	Associations for MIR3682_associations
	MIR3682 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MIR3682 Gene (Entity type)	ENSG00000265452 - microRNA 3682
	GSE195663 cisplatin 7 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 neratinib OVCAR-8 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR3682 associations

Associations for MIR3682_associations

MIR3682 associations.tsv

A file from IDG as part of the Harmonizome project

MIR3682

ENSG00000265452 - microRNA 3682

GSE195663 cisplatin 7 v 1 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE128730 neratinib OVCAR-8 4 v 5 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 0 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 1 human dn

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.